Boltz-1 Seminar
Join the main authors of Boltz-1, Jeremy Wohlwend and Gabriele Corso, as they share more about best practices for their fully open-source model and a vision for the exponential progress of AI in life sciences. Boltz-1 achieves state-of-the-art performance at the level of AlphaFold3, democratizing protein-molecular interactions.
Stata Center, 5pm – 6pm
December 5, 2024 Register
Speakers
Jeremy Wohlwend
Abdul Latif Jameel Fellow '21Jeremy Wohlwend is a PhD candidate and Jameel Clinic Fellow, advised by Professor Regina Barzilay. His research is focused on developing machine learning methods in the healthcare domain. Born in Geneva, Switzerland, Wohlwend moved to the United States at the age of 16. He attended the International School of Boston for two years, where he…
Gabriele Corso
Gabriele Corso is a PhD student affiliated with MIT Jameel Clinic and MIT CSAIL. He is co-advised by Tommi Jaakkola and Regina Barzilay. His research focuses on developing novel ML frameworks to tackle challenging problems in structural biology and drug discovery. Corso completed his undergraduate degree at the University of Cambridge where he wrote his thesis under the…
I hope you can see the potential this body of work has for advancing our understanding of human biology and physiology, health and disease processes, and what is already taking off— designing and developing new therapies. It’s exhilarating!Eric Topol, MD
Founder & Director, Scripps Research Translational Institute
By open-sourcing this advance, the MIT Jameel Clinic and collaborators are democratizing access to cutting-edge structural biology tools. This landmark effort will accelerate the creation of life-changing medicines. Thank you, Regina Barzilay and the Boltz-1 team, for driving this profound leap forward!Mathai Mammen, MD, PhD
CEO, President and Chairman, Parabilis Medicines
Most drug discovery happens in companies. The societal impact of a MIT licensed version of AF3 will [be] orders of magnitude larger than the original publication. What a trio of juggernauts!Luca Naef
Co-founder & CTO, VantAI
RSVP to the Boltz-1 Seminar | December 5, 5pm-6pm
The RSVP limit for this event has been reached. If you would like to attend the event, please email us at jclinic-info@mit.edu!
